Aramis Biotechnologies, a company developing a new generation of biomanufacturing platforms in plants to meet current public health needs and cope with future pandemics, agreed to acquire Medicago research and development assets from Mitsubishi Chemical, a manufacturer of a broad variety of industrial materials and performance products. Financial terms were not disclosed.